Literature DB >> 14461400

Intradermal sensitivity testing in man with a purified vaccine for Q fever.

D B LACKMAN, E J BELL, J F BELL, E G PICKENS.   

Abstract

Entities:  

Keywords:  Q FEVER/immunology

Mesh：

Substances：

Year:  1962        PMID： 14461400      PMCID： PMC1522671          DOI： 10.2105/ajph.52.1.87

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  9 in total

1.  The biologic properties of Coxiella burnetii isolated from rodents collected in Utah.

Authors:  H G STOENNER; D B LACKMAN
Journal:  Am J Hyg       Date:  1960-01

2.  The epidemiology of Q fever in the United States.

Authors:  L LUOTO
Journal:  Am J Public Health Nations Health       Date:  1959-03

3.  Phase variation of the Nine Mile and other strains of Rickettsia burneti.

Authors:  M G STOKER; P FISET
Journal:  Can J Microbiol       Date:  1956-05       Impact factor: 2.419

4.  METHOD FOR THE PRODUCTION OF A PURIFIED DRY Q FEVER VACCINE.

Authors:  S Berman; R B Gochenour; G Cole; J P Lowenthal; A S Benenson
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

5.  Comparison of the immunogenic and anaphylactogenic properties of Rocky Mountain spotted fever vaccines prepared from infected yolk sacs and from infected tick tissue.

Authors:  D LACKMAN; R R PARKER
Journal:  Am J Public Health Nations Health       Date:  1948-10

6.  Diagnostic complement fixation. I. A method.

Authors:  A G OSLER; J H STRAUSS; M M MAYER
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1952-03

7.  The growth of Coxiella burnetii in embryonated eggs.

Authors:  R A ORMSBEE
Journal:  J Bacteriol       Date:  1952-01       Impact factor: 3.490

8.  Antibody response of human subjects to epidemic typhus vaccine three to eight years after previous immunization.

Authors:  E S MURRAY; A OFSTROCK; J C SNYDER
Journal:  J Immunol       Date:  1952-02       Impact factor: 5.422

9.  Relationships among complement-fixing values, infectious endpoints, and death curves in experimental Coxiella burnetii infection.

Authors:  R A ORMSBEE; D B LACKMAN; E G PICKENS
Journal:  J Immunol       Date:  1951-10       Impact factor: 5.422
  9 in total
  17 in total

1.  Preparation of phase 1Q fever antigen suitable for vaccine use.

Authors:  D S Spicer; A N DeSanctis
Journal:  Appl Environ Microbiol       Date:  1976-07       Impact factor: 4.792

2.  Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

3.  Q fever as an occupational illness at the National Institutes of Health.

Authors:  R A Bayer
Journal:  Public Health Rep       Date:  1982 Jan-Feb       Impact factor: 2.792

4.  Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation.

Authors:  T R Jerrells; L P Mallavia; D J Hinrichs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

5.  Experimental model for dermal granulomatous hypersensitivity in Q fever.

Authors:  M S Ascher; M A Berman; D Parker; J L Turk
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.

Authors:  David M Waag; Marilyn J England; Christopher R Bolt; Jim C Williams
Journal:  Clin Vaccine Immunol       Date:  2008-08-13

Review 7.  Q fever.

Authors:  L G Reimer
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.

Authors:  J C Williams; T A Damrow; D M Waag; K Amano
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

9.  CONVERSION OF THE PHASE I ANTIGEN OF COXIELLA BURNETII TO HAPTEN BY PHENOL TREATMENT.

Authors:  R L ANACKER; W T HASKINS; D B LACKMAN; E RIBI; E G PICKENS
Journal:  J Bacteriol       Date:  1963-05       Impact factor: 3.490

10.  Q fever - a review.

Authors:  T J Marrie
Journal:  Can Vet J       Date:  1990-08       Impact factor: 1.008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.